GT201400093A - COMPOSITION WITH A PROTON PUMP INHIBITOR AND A H2 ANTAGONIST - Google Patents
COMPOSITION WITH A PROTON PUMP INHIBITOR AND A H2 ANTAGONISTInfo
- Publication number
- GT201400093A GT201400093A GT201400093A GT201400093A GT201400093A GT 201400093 A GT201400093 A GT 201400093A GT 201400093 A GT201400093 A GT 201400093A GT 201400093 A GT201400093 A GT 201400093A GT 201400093 A GT201400093 A GT 201400093A
- Authority
- GT
- Guatemala
- Prior art keywords
- composition
- proton pump
- pump inhibitor
- antagonist
- famotidine
- Prior art date
Links
Abstract
LA PRESENTE INVENCIÓN SE REFIERE A UNA COMPOSICIÓN FARMACÉUTICA ORAL QUE COMPRENDE LA COMBINACIÓN DE UN INHIBIDOR DE LA BOMBA DE PROTONES (IBP) Y UN ANTAGONISTA H2 (AH2) Y SUS SALES FARMACÉUTICAMENTE ACEPTABLES, ADICIONALMENTE VEHÍCULOS O EXCIPIENTES FARMACÉUTICAMENTE ACEPTABLES; ASÍ COMO A UN PROCESO PARA LA FABRICACIÓN DE LA COMPOSICIÓN Y AL USO DE LA COMBINACIÓN RABEPRAZOL - FAMOTIDINA O DEXRABEPRAZOL - FAMOTIDINA CON ACTIVIDAD TERAPÉUTICA SINÉRGICA INDICADA PARA EL TRATAMIENTO DE ENFERMEDADES DE REFLUJO GASTROESOFÁGICO (ERGE), ESCAPE ÁCIDO NOCTURNO (NAB), ÚLCERA PÉPTICA Y/O ERRADICACIÓN DE H. PYLORI.THE PRESENT INVENTION CONCERNS AN ORAL PHARMACEUTICAL COMPOSITION THAT INCLUDES THE COMBINATION OF A PROTON PUMP INHIBITOR (IBP) AND A H2 STAFF (AH2) AND ITS PHARMACEUTICALLY ACCEPTABLE OR EXCITING VEHICLES ACCEPTABLE; AS WELL AS A PROCESS FOR PRODUCING THE COMPOSITION AND THE USE OF THE COMBINATION RABEPRAZOLE - famotidine or DEXRABEPRAZOL - famotidine synergic therapeutic for the treatment of gastroesophageal reflux disease (GERD), ESCAPE ACID NOCTURNO (NAB), peptic ulcer AND / OR ERADICATION OF H. PYLORI.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MX2013006980A MX354999B (en) | 2013-06-18 | 2013-06-18 | Composition with a proton-pump inhibitor and an h2 antagonist. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GT201400093A true GT201400093A (en) | 2015-11-16 |
Family
ID=51610703
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GT201400093A GT201400093A (en) | 2013-06-18 | 2014-05-13 | COMPOSITION WITH A PROTON PUMP INHIBITOR AND A H2 ANTAGONIST |
Country Status (8)
| Country | Link |
|---|---|
| BR (1) | BR102014014857A2 (en) |
| CL (1) | CL2014001255A1 (en) |
| CO (1) | CO7020186A1 (en) |
| CR (1) | CR20140220A (en) |
| DO (1) | DOP2014000103A (en) |
| GT (1) | GT201400093A (en) |
| MX (1) | MX354999B (en) |
| PE (1) | PE20150164A1 (en) |
-
2013
- 2013-06-18 MX MX2013006980A patent/MX354999B/en active IP Right Grant
-
2014
- 2014-05-12 PE PE2014000677A patent/PE20150164A1/en not_active Application Discontinuation
- 2014-05-12 CR CR20140220A patent/CR20140220A/en unknown
- 2014-05-12 DO DO2014000103A patent/DOP2014000103A/en unknown
- 2014-05-12 CO CO14101483A patent/CO7020186A1/en not_active Application Discontinuation
- 2014-05-13 CL CL2014001255A patent/CL2014001255A1/en unknown
- 2014-05-13 GT GT201400093A patent/GT201400093A/en unknown
- 2014-06-17 BR BR102014014857-4A patent/BR102014014857A2/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| CL2014001255A1 (en) | 2014-10-10 |
| BR102014014857A2 (en) | 2015-06-02 |
| PE20150164A1 (en) | 2015-02-25 |
| DOP2014000103A (en) | 2014-12-31 |
| CO7020186A1 (en) | 2014-08-11 |
| CR20140220A (en) | 2014-08-21 |
| MX2013006980A (en) | 2014-12-19 |
| MX354999B (en) | 2018-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CR20190301A (en) | Amino-triazolopyridine compounds and their use in treating cancer | |
| NI201600058A (en) | RING-FUSED BICYCLIC PYRIDYL-DERIVED COMPOUNDS AS FGFR4 INHIBITORS | |
| PE20141906A1 (en) | ESKETAMINE FOR THE TREATMENT OF DEPRESSION REFRACTORY TO TREATMENT OR RESISTANT TO TREATMENT | |
| SV2015005115A (en) | DERIVATIVES OF PIRAZOLOPIRROLIDINE AND ITS USE IN THE TREATMENT OF DISEASES | |
| CU20170172A7 (en) | 4,6-DIAMINOQUINOLIN-3-CARBONITRILS SUBSTITUTED USEFUL AS ANALGESIC, ANTIPIRÉTIC OR ANTIINFLAMATORIOS AND ANTINEOPLÁSICOS AGENTS | |
| UY32455A (en) | AMINOTETRALINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT, AND ITS USES IN THERAPY | |
| UY33480A (en) | THERAPEUTIC COMPOUNDS, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT, TREATMENT METHOD AND ITS USE FOR THE MANUFACTURE OF A MEDICINAL PRODUCT. | |
| CR20120264A (en) | COMPOUNDS | |
| CR11510A (en) | USE OF A GAMMA-SECRETASE INHIBITOR FOR CANCER TREATMENT | |
| CL2015002608A1 (en) | Amino-pyrazole compound and related medicinal uses. | |
| SV2011004061A (en) | ARIL-PIRIDINAS AS INHIBITORS OF SINTASA DE ALDOSTERONA | |
| ECSP12012318A (en) | PIRAZOLIL QUINAZOLINA CINASA INHIBITORS | |
| CO6400220A2 (en) | SULFONAMIDE DERIVATIVES | |
| CL2017003066A1 (en) | Compositions of amorphous calcium carbonate for administration by inhalation, sublingual or buccal | |
| HN2012000023A (en) | COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITARY DISEASES | |
| CO2017002268A2 (en) | Spirocyclic cathepsin c inhibitors | |
| CR20120213A (en) | METHODS FOR TREATMENT OF CANCER USING NOTCH ANTAGONISTS | |
| CL2019002900A1 (en) | Benzoazepine analogs as bruton tyrosine kinase inhibitors. | |
| CO7350640A2 (en) | Dimeric compounds | |
| UY32052A (en) | 5-REPLACED AMINOPIRAZOLS AND USE OF THE SAME | |
| GT201700194A (en) | FORMULATION OF THEROPHENSIN AND BETABLOCKING COMBINATION | |
| CO6321288A2 (en) | SALES OF HIV INHIBITING COMPOUNDS | |
| ECSP11011405A (en) | COMBINATION THERAPY USED BY AN ANTI-EGFR AGENT OR AGENTS SPECIFIC INHIBITORS OF IGF-1R | |
| CL2015002466A1 (en) | Organic compound formulations | |
| UY32042A (en) | 2-AMINOPIRIMIDINE COMPOUNDS AS POWERFUL INHIBITORS OF HSP-90 |